As the name implies, Allume is all about lighting your pathway to a successful commercial launch of a new pharmaceutical or biotech product
Drawing on insights and experience from over 100 global launches, our integrated launch planning solution provides you access to the deep expertise of Quintiles to help you map and navigate the complex path from clinical development to commercialization.
Helping small to medium-sized companies navigate a complex marketplace
Allume™ from Quintiles delivers
- Achieve optimum value across different geographies and ease of market entry.
- Efficiently manage costs.
- Retain control of your asset throughout the entire process.
- Create a streamlined launch plan.
- Increase confidence for you and your investor.
A complete, integrated solution from start to finish
- Customized approach for your company and product.
- Real-world commercial insights and experience.
- Strategic consultative support and research.
- Sophisticated, intuitive web-based planning & tracking platform.
Successful product launches are in our DNA
- Regulatory, clinical, marketing, market access, and sales operations expertise.
- Strategic plan and tactical implementation roapmap.
- Dedicated project management to ensure efficient, timely execution.
- 110 global product launches in 34 countries.
- More than 70% of new molecular entities approved between 2004 and 2010.
- 75% of biologicals approved between 2004 and 2010.
- Nearly 80% of “breakthrough” products between 2004 and 2010.
- We helped develop or commercialize all 50 top products on the market today.
the fact sheet, then contact us and let's talk.